Novo Nordisk seeks orders to block Eli Lilly weight-loss drug ads
Lilly on Friday denied any wrongdoing, saying it stood by its advertising and would vigorously defend itself.
Novo and Lilly are battling for dominance in the obesity drug market
Lilly on Friday denied any wrongdoing, saying it stood by its advertising and would vigorously defend itself.
Novo and Lilly are battling for dominance in the obesity drug market